Preclinical Ophthalmology CRO
No animal study can predict with certainty how an ophthalmology therapy will perform in human subjects, but with over 1500 validated models, PharmaLegacy ensures they come as close as possible.
Why wait months to start your study? PharmaLegacy’s ophthalmology models are maintained for ready availability so we can start your study in just two weeks!
Your data can’t be any better than your models or the people who run your studies. PharmaLegacy has been developing models for decades, rigorously validating each one. Our scientists average 15 years of professional scientific experience and 5 years with PharmaLegacy. There is a good reason why 12 of the top 20 pharmaceutical companies trust PharmaLegacy. You can expect more when you choose PharmaLegacy as your ophthalmology CRO.
Comprehensive Capabilities for Demanding Ophthalmology Studies
Delivering results in ophthalmology studies isn’t only about having a world-class selection of models. It’s also about having the expertise and capabilities to use them to maximum effect. PharmaLegacy can offer any necessary dosing schedule and administration method (anterior chamber injection, intravitreal injection, retrobulbar injection, subretinal injection, suprachoroidal injection, eye drop, etc.). We also are equipped to perform a wide range of ophthalmic examinations, including:
When you choose PharmaLegacy as your preclinical ophthalmology CRO, we aspire to get you the most clinically relevant data at a price you can afford and on a timeline that puts your pipeline at an advantage.
Why wait months to start your ophthalmology study? We maintain ready availability of all of our advertised models and can usually begin a study in under two weeks!
With our massive catalog of over 1500 readily available models, our scientific staff averaging over 15 years of experience, and our surprisingly affordable pricing, when you choose PharmaLegacy as your preclinical ophthalmology CRO, you can expect more.